Methylation-specific electrochemical biosensing strategy for highly sensitive and quantitative analysis of promoter methylation of tumor-suppressor gene in real sample

被引:15
|
作者
Liu, Shenglin [1 ,2 ]
Zhang, Xuejun [1 ]
Zhao, Kebin [3 ]
机构
[1] Tianjin Med Univ, Dept Immunol, Tianjin 300070, Peoples R China
[2] Xiqing Hosp Tianjin, Dept Lab Med, Tianjin 300380, Peoples R China
[3] Shanxi Med Univ, Hosp 1, Dept Lab Med, Taiyuan 030001, Peoples R China
基金
美国国家科学基金会;
关键词
Electrochemical biosensor; DNA methylation; Tumor suppressor gene; High sensitivity; Practicability; SURFACE-PLASMON RESONANCE; WNT ANTAGONIST GENES; DNA METHYLATION; BREAST-CANCER; METHYLTRANSFERASE ACTIVITY; PCR ASSAY; HYPERMETHYLATION; AMPLIFICATION; INACTIVATION; EPIGENETICS;
D O I
10.1016/j.jelechem.2016.03.001
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A handy and practical methylation-specific electrochemical biosensing strategy was developed by integrating bisulfite conversion and PCR amplification with high efficient electrochemical biosensor. The dual signal amplification of PCR and enzyme-catalyzed electrochemical sensing resulted in higher sensitivity of the proposed method. The primers for PCR and capture probes for amplicons binding were specifically designed to distinguish different CpG islands in the promoter regions of target gene, which further enhanced the specificity. The designed method showed very high sensitivity and specificity for DNA methylation analysis and was able to respond to about 8 copies of methylated promotor of secreted frizzled-related protein 2 (SFRP2) gene in 10,000 times of unmethylated genomic DNA. Moreover, the established biosensor was successfully verified for quantitative detection of SFRP2 promotor methylation in breast primary tumor tissues and subtlemonitor of SFRP2 promotor methylation status changes in real sample with the demethylating agent treatment This proposed strategy presented a simple and pragmatic platform toward high sensitive and quantitative detection promoter methylation of tumor-suppressor gene for early diagnosis and prognostic assessment of cancer, as well as monitoring response to therapeutic agents. (C) 2016 Published by Elsevier B.V.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 38 条
  • [21] Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
    Li Yu
    Chunhui Liu
    Jeff Vandeusen
    Brian Becknell
    Zunyan Dai
    Yue-Zhong Wu
    Aparna Raval
    Te-Hui Liu
    Wei Ding
    Charlene Mao
    Shujun Liu
    Laura T Smith
    Stephen Lee
    Laura Rassenti
    Guido Marcucci
    John Byrd
    Michael A Caligiuri
    Christoph Plass
    Nature Genetics, 2005, 37 : 265 - 274
  • [22] Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: Comparison with methylation-specific PCR technique and clinical significance
    Lee, Su Man
    Lee, Won Kee
    Kim, Dong Sun
    Park, Jae Yong
    MOLECULAR MEDICINE REPORTS, 2012, 5 (01) : 239 - 244
  • [23] Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation
    Loeb, DM
    Evron, E
    Patel, CB
    Sharma, PM
    Niranjan, B
    Buluwela, L
    Weitzman, SA
    Korz, D
    Sukumar, S
    CANCER RESEARCH, 2001, 61 (03) : 921 - 925
  • [24] Glutathione Peroxidase 7 is a Potential Tumor Suppressor Gene Silenced by Location-Specific Promoter Methylation in Barrett's Tumorigenesis
    Peng, DunFa
    Hu, Tianling
    Zaika, Elena
    Soutto, Mohammed
    Zaika, Alexander
    El-Rifai, Wael
    GASTROENTEROLOGY, 2012, 142 (05) : S127 - S127
  • [25] Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: Comparison with methylation-specific PCR technique and clinical significance
    Lee, Eung-Seok
    Issa, Jean-Pierre
    Roberts, Dianna B.
    Williams, Michelle D.
    Weber, Randal S.
    Kies, Merrill S.
    El-Naggar, Adel K.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2664 - 2672
  • [26] Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
    Muriel X. G. Draht
    Kim M. Smits
    Valérie Jooste
    Benjamin Tournier
    Martijn Vervoort
    Chantal Ramaekers
    Caroline Chapusot
    Matty P. Weijenberg
    Manon van Engeland
    Veerle Melotte
    Clinical Epigenetics, 2016, 8
  • [27] p16 tumor-suppressor gene in head and neck squamous cell carcinoma: Promoter methylation and loss of protein expression with clinical correlation in 121 patients
    Ai, L
    Stephenson, KK
    Zuo, C
    Mukunyadzi, P
    Suen, JY
    Hanna, E
    Fan, CY
    MODERN PATHOLOGY, 2003, 16 (01) : 217A - 217A
  • [28] p16 tumor-suppressor gene in head and neck squamous cell carcinoma: Promoter methylation and loss of protein expression with clinical correlation in 121 patients
    Ai, L
    Stephenson, KK
    Zuo, C
    Mukunyadzi, P
    Suen, JY
    Hanna, E
    Fan, CY
    LABORATORY INVESTIGATION, 2003, 83 (01) : 217A - 217A
  • [29] Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
    Draht, Muriel X. G.
    Smits, Kim M.
    Jooste, Valerie
    Tournier, Benjamin
    Vervoort, Martijn
    Ramaekers, Chantal
    Chapusot, Caroline
    Weijenberg, Matty P.
    van Engeland, Manon
    Melotte, Veerle
    CLINICAL EPIGENETICS, 2016, 8
  • [30] Comparison of Quantitative Analysis of Methylated Alleles Real-Time PCR and Methylation-Specific MLPA for Molecular Diagnosis of Beckwith-Wiedemann Syndrome
    Bergallo, Massimiliano
    Galliano, Ilaria
    Montanari, Paola
    Calvi, Cristina
    Dapra, Valentina
    Carli, Diana
    Russo, Silvia
    Mussa, Alessandro
    Ferrero, Giovanni Battista
    PATHOBIOLOGY, 2019, 86 (04) : 217 - 224